Mazdutide is a novel GLP-1/glucagon dual receptor agonist investigated in preclinical and early clinical research for its combined metabolic effects. By co-activating GLP-1 and glucagon receptors, Mazdutide is studied for its capacity to reduce body weight, improve glycemic control, increase energy expenditure, and favorably modulate lipid metabolism in research models. The dual receptor engagement distinguishes it from single-agonist GLP-1 analogs and provides researchers a tool for studying complementary metabolic pathways simultaneously. PeptideBull supplies Mazdutide at research-grade purity. Not for human consumption.
Related Products
